Recovery from chronic hepatitis C?

Long-term response to chronic hepatitis C treatment suggests complete recovery.

July 6, 2000

New York, July 5, 2000 (Praxis Press) The traditional treatment for chronic hepatitis C combines interferon alfa (3 million units subcutaneously three times a week) with ribavirin (1.0 or 1.2 g daily) for a duration of 6 to 12 months. Studies show that the rate of long-term response is 40 percent 6 months after the end of the treatment but do not document the issue of late relapse in sustained complete responders. In a 12–month follow–up study of patients after therapy, Hélène Fontaine and colleagues found that a virological response six months after discontinuation of the combination treatment is predictive of a 97.8 percent rate of long-term complete response (see paper). The study indicates that a sustained response -- defined as a normal concentration of serum alanine aminotransferase and negative HCV viraemia by PCR 6 months after discontinuation of therapy -- is associated 6 months later with an eradication of HCV RNA and a biochemical normalization and histopathological improvement that strongly suggest complete recovery, since there is no putative genomic integration of HCV RNA.

Popular Now

  1. National Academies Detail the State of Weed Science
  2. Neural Mechanism Links Alcohol Consumption to Binge Eating
  3. Image of the Day: Monkey Business
    Image of the Day Image of the Day: Monkey Business

    For the first time, researchers have documented interspecies sexual behavior between a male Japanese macaque and a female sika deer.

  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech